COMMUNIQUÉS West-GlobeNewswire

-
Roche’s Tecentriq combined with lurbinectedin shows significant survival benefit in extensive-stage small cell lung cancer
03/06/2025 -
Press Release: Rilzabrutinib granted orphan drug designation in the US for sickle cell disease
03/06/2025 -
Communiqué de presse : Le rilzabrutinib obtient la désignation de médicament orphelin aux États-Unis pour le traitement de la drépanocytose
03/06/2025 -
argenx to Present at Goldman Sachs 46th Annual Global Healthcare Conference
03/06/2025 -
Extendicare Acquires Nine Long-Term Care Homes from Revera
03/06/2025 -
Live from ASCO 2025 | Ascentage Pharma Releases Promising Clinical Data on Alrizomadlin Monotherapy and Combinations in Solid Tumors
03/06/2025 -
Live from ASCO 2025 | Ascentage Pharma Presents Clinical Data on Bcl-2 Inhibitor Lisaftoclax in Venetoclax-Refractory Patients in Oral Report
03/06/2025 -
Nxera Pharma to Receive US$15 Million from Neurocrine Biosciences Following Dosing of First Patient in Phase 3 Trial of NBI-1117568
03/06/2025 -
Saus Trades’ Latest eBook Helps Traders Tackle the Psychological Barriers to Consistent Profitability
03/06/2025 -
Canadian Health Tech Cuts Hospital Emergency Department Triage Time by up to 60%
03/06/2025 -
Eupraxia Pharmaceuticals Announces Voting Results from Annual General and Special Meeting of Shareholders
03/06/2025 -
Kura Oncology and Kyowa Kirin Report Positive Pivotal Ziftomenib Monotherapy Data at 2025 ASCO Annual Meeting
03/06/2025 -
Evils of Sham Peer Review Exposed in the Journal of American Physicians and Surgeons
02/06/2025 -
Quest PharmaTech Provides Corporate Update
02/06/2025 -
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/06/2025 -
Harvard Bioscience Appoints John Duke to Board of Directors
02/06/2025 -
First Insight Unveils New MaximEyes Brand Website to Reflect Innovation in Eye Care Technology
02/06/2025 -
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/06/2025 -
Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes
02/06/2025
Pages